China's diabetes treatment firm Microtech Medical climbs in Hong Kong debut

MicroTech Medical (Hangzhou)

19/10/2021 04:43

** Shares of Chinese diabetes treatment and monitoring
devices producer MicroTech Medical Hangzhou Co Ltd  2235.HK 
trade as high as HK$31.45 each in Hong Kong trading debut on
Tuesday, up 3.1% from the offer price 
    ** Stock last up 1% from the offer price of HK$30.50 each
    ** Zhejiang, China-based company sold 63.53 mln shares in
Hong Kong IPO, raising HK$1.94 bln ($249.4 mln) to fund clinical
trials and commercialization of its core products, to expand
production and to fund pre-clinical studies  urn:newsml:reuters.com:*:nFWN2R10RL
    ** The Hang Seng Commerce & Industry Index  .HSNC  rises
1.6% and the healthcare index  .HSCIH  climbs 0.9%
    ** The Hang Seng China Enterprises Index  .HSCE  gains 1.6%
and the benchmark index  .HSI  is up 1.4%
($1 = 7.7782 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))